Klarzen Pharmaceuticals Private Limited
About Klarzen Pharmaceuticals Private Limited
Data last updated:
Klarzen Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2019PTC356373. Its GSTIN is 10AAHCK8570F1ZN (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rajendra Bhagat (Managing Director) and Sangita Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Banarshi Bhagat C – 2/293 Gali No – 4 Sonia Vihar Nanaksur, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.53 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3,431 (net margin 0.8%) and EBITDA of ₹4,587 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years and 6% over five years.
Company details
Contact details
Klarzen Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC/O – Banarshi Bhagat C – 2/293 Gali No – 4 Sonia Vihar Nanaksur, Delhi, India – 110094
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Klarzen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Klarzen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Klarzen Pharmaceuticals Private Limited, buy the company report.
Financials of Klarzen Pharmaceuticals Private Limited
FY 2025 filings availableKlarzen Pharmaceuticals Private Limited reported revenue of ₹4.53 Lakh (up 155% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 155% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,587 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,431 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Klarzen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Klarzen Pharmaceuticals Private Limited
Klarzen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Bhagat | Managing Director | 18 Oct 2019 | 7 Years 0 Months | Current |
| Sangita Devi | Director | 15 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Klarzen Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Accost Pharmaceuticals (India) Private Limited | ₹4.57 Lakh (FY 2024) | -27.0% | Rajendra Nagar, Patna, Bihar, India | |||
| Dare and Vision Pharmaceuticals Private Limited | ₹4.56 Lakh (FY 2024) | 72.0% | Jabalpur, Madhya Pradesh, India | |||
| Folk Pharmaceuticals Private Limited | ₹4.55 Lakh (FY 2024) | Patna, Bihar, India | ||||
| Klarzen Pharmaceuticals Private Limitedthis company | ₹4.53 Lakh (FY 2025) | ₹3,431 | 0.8% | 155.0% | Delhi, India | |
| Dux Ducis Pharmaceuticals Private Limited | ₹4.46 Lakh (FY 2019) | -56.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Klarzen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Klarzen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Klarzen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Klarzen Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCK8570F1ZN | Bihar | Active | 02 Dec 2019 |
To see the full GST registrations and return filing status of Klarzen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Klarzen Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Sangita Devi ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Klarzen Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 October 2019 (7+ years old) and is registered under CIN U24239DL2019PTC356373.
Klarzen Pharmaceuticals has 2 current directors:
- Rajendra Bhagat - Managing Director
- Sangita Devi - Director
The latest financial statements of Klarzen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Klarzen Pharmaceuticals is 10AAHCK8570F1ZN, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Klarzen Pharmaceuticals is U24239DL2019PTC356373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Klarzen Pharmaceuticals was incorporated on 18 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Klarzen Pharmaceuticals by revenue are Accost Pharmaceuticals (India) Private Limited, Dare and Vision Pharmaceuticals Private Limited, Folk Pharmaceuticals Private Limited, Dux Ducis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sangita Devi ceased to be Additional Director on 30 Sep 2022. Sangita Devi was appointed as Director on 15 Feb 2022. Lakshman Kumar ceased to be Director on 12 Feb 2022. Klarzen Pharmaceuticals has 4 board changes on record in total.
The registered office of Klarzen Pharmaceuticals is at CO – Banarshi Bhagat C – 2293 Gali No – 4 Sonia Vihar Nanaksur, Delhi, India – 110094.
Klarzen Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Klarzen Pharmaceuticals can be reached at its registered office: CO – Banarshi Bhagat C – 2293 Gali No – 4 Sonia Vihar Nanaksur, Delhi, India – 110094.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
